Welcome to our dedicated page for GTENW news (Ticker: GTENW), a resource for investors and traders seeking the latest updates and insights on GTENW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GTENW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GTENW's position in the market.
Gores Holdings X (NASDAQ: GTENU) has announced the pricing of its upsized initial public offering of 31,200,000 units at $10.00 per unit, totaling $312 million. Each unit comprises one Class A ordinary share and one-fourth of one warrant, with each whole warrant allowing the purchase of one Class A ordinary share at $11.50.
The units will begin trading on the Nasdaq Global Market on May 2, 2025, under "GTENU". Once separate trading begins, the Class A shares and warrants will trade under "GTEN" and "GTENW" respectively. Santander US Capital Markets LLC is the sole underwriter and has a 45-day option to purchase up to 4,680,000 additional units to cover over-allotments.
